» Articles » PMID: 33445063

Palmitic Acid Methyl Ester Inhibits Cardiac Arrest-induced Neuroinflammation and Mitochondrial Dysfunction

Abstract

We previously discovered that palmitic acid methyl ester (PAME) is a potent vasodilator released from the sympathetic ganglion with vasoactive properties. Post-treatment with PAME can enhance cortical cerebral blood flow and functional learning and memory, while inhibiting neuronal cell death in the CA1 region of the hippocampus under pathological conditions (i.e. cerebral ischemia). Since mechanisms underlying PAME-mediated neuroprotection remain unclear, we investigated the possible neuroprotective mechanisms of PAME after 6 min of asphyxial cardiac arrest (ACA, an animal model of global cerebral ischemia). Our results from capillary-based immunoassay (for the detection of proteins) and cytokine array suggest that PAME (0.02 mg/kg) can decrease neuroinflammatory markers, such as ionized calcium binding adaptor molecule 1 (Iba1, a specific marker for microglia/macrophage activation) and inflammatory cytokines after cardiopulmonary resuscitation. Additionally, the mitochondrial oxygen consumption rate (OCR) and respiratory function in the hippocampal slices were restored following ACA (via Seahorse XF24 Extracellular Flux Analyzer) suggesting that PAME can ameliorate mitochondrial dysfunction. Finally, hippocampal protein arginine methyltransferase 1 (PRMT1) and PRMT8 are enhanced in the presence of PAME to suggest a possible pathway of methylated fatty acids to modulate arginine-based enzymatic methylation. Altogether, our findings suggest that PAME can provide neuroprotection in the presence of ACA to alleviate neuroinflammation and ameliorate mitochondrial dysfunction.

Citing Articles

The role of serum/glucocorticoid-regulated kinase 1 in brain function following cerebral ischemia.

Wu C, Zhang Y, Xu L, Huang Z, Zou P, Clemons G J Cereb Blood Flow Metab. 2024; 44(7):1145-1162.

PMID: 38235747 PMC: 11179613. DOI: 10.1177/0271678X231224508.


Photobiomodulation attenuates oligodendrocyte dysfunction and prevents adverse neurological consequences in a rat model of early life adversity.

Huang Z, Zhang Y, Ma X, Feng Y, Zong X, Jordan J Theranostics. 2023; 13(3):913-930.

PMID: 36793860 PMC: 9925323. DOI: 10.7150/thno.78777.


Neuroprotective Effect of miR-483-5p Against Cardiac Arrest-Induced Mitochondrial Dysfunction Mediated Through the TNFSF8/AMPK/JNK Signaling Pathway.

Zhang Q, Zhan H, Liu C, Zhang C, Wei H, Li B Cell Mol Neurobiol. 2022; 43(5):2179-2202.

PMID: 36266523 PMC: 10287582. DOI: 10.1007/s10571-022-01296-3.


Protein arginine methyltransferase 8 modulates mitochondrial bioenergetics and neuroinflammation after hypoxic stress.

Silva A, Wu C, Clemons G, Acosta C, Chen C, Possoit H J Neurochem. 2021; 159(4):742-761.

PMID: 34216036 PMC: 8595568. DOI: 10.1111/jnc.15462.

References
1.
Lo L, Dong R, Lyu Q, Lai K . The Protein Arginine Methyltransferase PRMT8 and Substrate G3BP1 Control Rac1-PAK1 Signaling and Actin Cytoskeleton for Dendritic Spine Maturation. Cell Rep. 2020; 31(10):107744. DOI: 10.1016/j.celrep.2020.107744. View

2.
Guo C, Sun L, Chen X, Zhang D . Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2014; 8(21):2003-14. PMC: 4145906. DOI: 10.3969/j.issn.1673-5374.2013.21.009. View

3.
Scaramuzzino C, Monaghan J, Milioto C, Lanson Jr N, Maltare A, Aggarwal T . Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo. PLoS One. 2013; 8(4):e61576. PMC: 3631215. DOI: 10.1371/journal.pone.0061576. View

4.
Di Lorenzo A, Bedford M . Histone arginine methylation. FEBS Lett. 2010; 585(13):2024-31. PMC: 3409563. DOI: 10.1016/j.febslet.2010.11.010. View

5.
Yang J, Mukda S, Chen S . Diverse roles of mitochondria in ischemic stroke. Redox Biol. 2018; 16:263-275. PMC: 5854930. DOI: 10.1016/j.redox.2018.03.002. View